Review




Structured Review

Pyrosequencing Inc pyrosequencing-based microbiome analysis
Microbial diversity and profile in cancer patients (‘diseased’) did not differ significantly from healthy controls, but healthy individuals formed a sub-cluster within the diseased cohort. ( a ) No alterations were observed in alpha diversity between the two groups at the RSV level using ANOVA. ( b ) <t>Microbiome</t> profile of healthy controls clustered within the diseased subjects in a PCoA plot (RSV level). ( c ) LEfSe analysis of taxa associated with healthy subjects and SCC, including the top 100 most abundant genera. ( d – h ) Relative abundance of the genera Bifidobacterium , Pasteurellaceae , Eubacterium , Veillonella, and Fusobacterium in healthy subjects compared to patients.
Pyrosequencing Based Microbiome Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing-based+analysis/pyrosequencing+based+microbiome+analysis/pmc07538973-37-17-17
Average 90 stars, based on 1 article reviews
pyrosequencing-based microbiome analysis - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma"

Article Title: Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma

Journal: Scientific Reports

doi: 10.1038/s41598-020-73515-0

Microbial diversity and profile in cancer patients (‘diseased’) did not differ significantly from healthy controls, but healthy individuals formed a sub-cluster within the diseased cohort. ( a ) No alterations were observed in alpha diversity between the two groups at the RSV level using ANOVA. ( b ) Microbiome profile of healthy controls clustered within the diseased subjects in a PCoA plot (RSV level). ( c ) LEfSe analysis of taxa associated with healthy subjects and SCC, including the top 100 most abundant genera. ( d – h ) Relative abundance of the genera Bifidobacterium , Pasteurellaceae , Eubacterium , Veillonella, and Fusobacterium in healthy subjects compared to patients.
Figure Legend Snippet: Microbial diversity and profile in cancer patients (‘diseased’) did not differ significantly from healthy controls, but healthy individuals formed a sub-cluster within the diseased cohort. ( a ) No alterations were observed in alpha diversity between the two groups at the RSV level using ANOVA. ( b ) Microbiome profile of healthy controls clustered within the diseased subjects in a PCoA plot (RSV level). ( c ) LEfSe analysis of taxa associated with healthy subjects and SCC, including the top 100 most abundant genera. ( d – h ) Relative abundance of the genera Bifidobacterium , Pasteurellaceae , Eubacterium , Veillonella, and Fusobacterium in healthy subjects compared to patients.

Techniques Used:

Radiochemotherapy in cancer patients substantially impacts the microbial profile. ( a ) Shannon Diversity Index did not reveal significant differences in the salivary microbiome between patients before and after therapy at the RSV level using ANOVA. ( b ) Treatment had a significant impact on the microbiome profile (RDA plot, RSV level). ( c ) Bar plot of the microbiome composition before and after therapy, including the 35 most abundant genera. Taxa are displayed from bottom to top. ( d ) Specific taxa that were significantly increased before or after therapy are plotted in a LEfSe including the 35 most abundant genera.
Figure Legend Snippet: Radiochemotherapy in cancer patients substantially impacts the microbial profile. ( a ) Shannon Diversity Index did not reveal significant differences in the salivary microbiome between patients before and after therapy at the RSV level using ANOVA. ( b ) Treatment had a significant impact on the microbiome profile (RDA plot, RSV level). ( c ) Bar plot of the microbiome composition before and after therapy, including the 35 most abundant genera. Taxa are displayed from bottom to top. ( d ) Specific taxa that were significantly increased before or after therapy are plotted in a LEfSe including the 35 most abundant genera.

Techniques Used:

The bacterial and fungal microbiome of healthy subjects and SCC patients is more similar before radiochemotherapy than after. Shannon Diversity of the ( a ) bacterial and ( b ) fungal communities at RSV level (ANOVA). Bar plot of the top 35 most abundant ( c ) bacterial and ( d ) fungal genera. Redundancy analysis of the ( e ) bacterial and ( f ) fungal profiles using ANOVA. Taxa listed in the bar-plot are displayed from bottom to top.
Figure Legend Snippet: The bacterial and fungal microbiome of healthy subjects and SCC patients is more similar before radiochemotherapy than after. Shannon Diversity of the ( a ) bacterial and ( b ) fungal communities at RSV level (ANOVA). Bar plot of the top 35 most abundant ( c ) bacterial and ( d ) fungal genera. Redundancy analysis of the ( e ) bacterial and ( f ) fungal profiles using ANOVA. Taxa listed in the bar-plot are displayed from bottom to top.

Techniques Used:

Related Articles

other:

Article Title: Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma
Article Snippet: One exception is the study by Hu et al. in 2013 , in which they performed a pyrosequencing-based microbiome analysis of plaque samples taken from subjects undergoing head-and-neck radiotherapy.



Similar Products

86
Pyrosequencing Inc pyrosequencing based analysis
Pyrosequencing Based Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing-based+analysis/16s+pyrosequencing+rrna/pm42128334-658-12-12
Average 86 stars, based on 1 article reviews
pyrosequencing based analysis - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Pyrosequencing Inc pyrosequencing-based methylation analysis
Pyrosequencing Based Methylation Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing-based+analysis/pyrosequencing+based+methylation+analysis/pm40647502-43-0-0
Average 90 stars, based on 1 article reviews
pyrosequencing-based methylation analysis - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Pyrosequencing Inc pyrosequencing-based bisulfite pcr analysis
Pyrosequencing Based Bisulfite Pcr Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing-based+analysis/bisulfite+pyrosequencing/pm39414799-158-1-0
Average 90 stars, based on 1 article reviews
pyrosequencing-based bisulfite pcr analysis - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Pyrosequencing Inc pyrosequencing-based analysis
Pyrosequencing Based Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing-based+analysis/pyrosequencingtm/pmc11485332-63-2-2
Average 90 stars, based on 1 article reviews
pyrosequencing-based analysis - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Pyrosequencing Inc pyrosequencing-based analysis of bacterial 16 s rrna (v3-v5 region)
Pyrosequencing Based Analysis Of Bacterial 16 S Rrna (V3 V5 Region), supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing-based+analysis/pyrosequencing+based+analysis+of+bacterial+16s+rrna++v3+v5+region+/pm37390712-146-22-16
Average 90 stars, based on 1 article reviews
pyrosequencing-based analysis of bacterial 16 s rrna (v3-v5 region) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Pyrosequencing Inc pyrosequencing-based analysis of bacterial 16s rdna
Pyrosequencing Based Analysis Of Bacterial 16s Rdna, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing-based+analysis/pyrosequencing+based+analysis+of+bacterial+16s+rdna/pm36535571-175-18-12
Average 90 stars, based on 1 article reviews
pyrosequencing-based analysis of bacterial 16s rdna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Pyrosequencing Inc pyrosequencing-based dna methylation analysis
(A) Diagram of the experimental design. The differences of the global methylation levels between donors, pre-HCT recipients and post-HCT recipients were assessed by <t>a</t> <t>pyrosequencing</t> based methylation assay of repetitive <t>DNA</t> elements (LINE1 and NBL2) in whole blood. (B) NBL2 ΔMet values between donors, pre-HCT recipients, and 1 month post-HCT recipients. (C) NBL2 ΔMet mean values between donors and recipients up to 12 months post-transplant. The dotted line marks the ΔMet mean value between donors and 1 month post-HCT recipients (ΔMet = 5.8450). During the follow up of the transplant, the mean values barely deviated from the initial post-HCT ΔMet. (D) LINE1 ΔMet values between donors, pre-HCT recipients and 1 month post-HCT recipients. (E) LINE1 ΔMet mean values between donors and recipients up to 12 months post-transplant. The dotted line marked the ΔMet mean value between donors and 1 month post-HCT recipients (ΔMet = 5.383).
Pyrosequencing Based Dna Methylation Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing-based+analysis/dna+methylation+pyrosequencing/pmc03579934-135-1-0
Average 90 stars, based on 1 article reviews
pyrosequencing-based dna methylation analysis - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


(A) Diagram of the experimental design. The differences of the global methylation levels between donors, pre-HCT recipients and post-HCT recipients were assessed by a pyrosequencing based methylation assay of repetitive DNA elements (LINE1 and NBL2) in whole blood. (B) NBL2 ΔMet values between donors, pre-HCT recipients, and 1 month post-HCT recipients. (C) NBL2 ΔMet mean values between donors and recipients up to 12 months post-transplant. The dotted line marks the ΔMet mean value between donors and 1 month post-HCT recipients (ΔMet = 5.8450). During the follow up of the transplant, the mean values barely deviated from the initial post-HCT ΔMet. (D) LINE1 ΔMet values between donors, pre-HCT recipients and 1 month post-HCT recipients. (E) LINE1 ΔMet mean values between donors and recipients up to 12 months post-transplant. The dotted line marked the ΔMet mean value between donors and 1 month post-HCT recipients (ΔMet = 5.383).

Journal: PLoS ONE

Article Title: DNA Methylation Dynamics in Blood after Hematopoietic Cell Transplant

doi: 10.1371/journal.pone.0056931

Figure Lengend Snippet: (A) Diagram of the experimental design. The differences of the global methylation levels between donors, pre-HCT recipients and post-HCT recipients were assessed by a pyrosequencing based methylation assay of repetitive DNA elements (LINE1 and NBL2) in whole blood. (B) NBL2 ΔMet values between donors, pre-HCT recipients, and 1 month post-HCT recipients. (C) NBL2 ΔMet mean values between donors and recipients up to 12 months post-transplant. The dotted line marks the ΔMet mean value between donors and 1 month post-HCT recipients (ΔMet = 5.8450). During the follow up of the transplant, the mean values barely deviated from the initial post-HCT ΔMet. (D) LINE1 ΔMet values between donors, pre-HCT recipients and 1 month post-HCT recipients. (E) LINE1 ΔMet mean values between donors and recipients up to 12 months post-transplant. The dotted line marked the ΔMet mean value between donors and 1 month post-HCT recipients (ΔMet = 5.383).

Article Snippet: Pyrosequencing-based DNA methylation analysis is relatively inexpensive, is very sensitive, and provides an interesting alternative to protein and mRNA detection in blood samples, allowing the development of novel biomarkers in a large array of human diseases.

Techniques: Methylation

Scatter plots showing DNA methylation in donors versus post-transplant recipients 1 month and 6 months post-HCT. Red dots represent CpG sites with methylation values altered more than 20% relative to donor values.

Journal: PLoS ONE

Article Title: DNA Methylation Dynamics in Blood after Hematopoietic Cell Transplant

doi: 10.1371/journal.pone.0056931

Figure Lengend Snippet: Scatter plots showing DNA methylation in donors versus post-transplant recipients 1 month and 6 months post-HCT. Red dots represent CpG sites with methylation values altered more than 20% relative to donor values.

Article Snippet: Pyrosequencing-based DNA methylation analysis is relatively inexpensive, is very sensitive, and provides an interesting alternative to protein and mRNA detection in blood samples, allowing the development of novel biomarkers in a large array of human diseases.

Techniques: DNA Methylation Assay, Methylation